Tobacco.org

Even Light Smokers Need to Quit, and a New Study Shows What Can Help Them 

An article in the current issue of Drug and Alcohol Dependence (Volume 77, Pages 311-314) provides new hope for smokers who may think that medicinal nicotine can't help them quit.

Researchers examined data from a previous trial involving 917 smokers randomized to a placebo or to the 2 mg Commit(R) lozenge marketed by GlaxoSmithKline (GSK) Consumer Healthcare. They found that 2 mg Commit can significantly increase light smokers' chances of quitting successfully. The analysis is the first of its kind that focuses specifically on light smokers, defined as people who smoke 15 cigarettes per day or less, and who smoke their first cigarette of the day more than 30 minutes after waking, an indicator of low tobacco dependence.

In the study, 45.7% of the light smokers using the Commit lozenge were still not smoking after 6 weeks, compared to 31.1% using placebo. After one year, the smokers using the Commit lozenge were almost twice as likely to still be abstinent from smoking.

Jump to full article »